+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Binge Eating Disorder Market - Global Forecast to 2030- Product Image
Binge Eating Disorder Market - Global Forecast to 2030- Product Image
Sale

Binge Eating Disorder Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5968299
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Binge Eating Disorder Market grew from USD 587.85 million in 2024 to USD 624.43 million in 2025. It is expected to continue growing at a CAGR of 6.05%, reaching USD 836.28 million by 2030.

Understanding the Binge Eating Disorder Landscape

Binge Eating Disorder (BED) has emerged as a critical public health concern, affecting individuals across age groups, genders, and socio-economic strata. Characterized by recurrent episodes of consuming large amounts of food accompanied by feelings of loss of control, BED carries profound clinical and psychosocial implications, from metabolic complications to heightened anxiety and depression. Over the past decade, growing recognition of BED’s prevalence has spurred advancements in clinical diagnostics and multifaceted treatment approaches. This executive summary synthesizes pivotal insights into current treatment paradigms, market dynamics, regulatory influences and evolving patient needs. Drawing on the latest qualitative and quantitative evidence, it offers decision-makers a concise yet comprehensive understanding of shifting market drivers, segmentation nuances and competitive landscapes. With an emphasis on actionable analysis, the following sections illuminate transformative shifts, policy impacts, segmentation intelligence, regional and company insights, and strategic recommendations. By bridging rigorous research with practical applications, this summary equips stakeholders to navigate the complexities of BED management and optimize outcomes for patients, providers and payers alike.

Transformative Shifts Reshaping Binge Eating Disorder Treatment

The BED treatment landscape is undergoing rapid transformation driven by technological innovation, policy reform and evolving patient expectations. Telehealth platforms and digital therapeutics have expanded access beyond traditional clinic walls, enabling remote nutritional counseling and virtual CBT sessions that accommodate diverse lifestyles. Simultaneously, regulatory bodies are streamlining approval pathways for novel pharmacotherapies, incentivizing pharmaceutical R&D into anti-obesity drugs, anticonvulsants and innovative antidepressant formulations. Moreover, integration of AI-based diagnostic tools is enhancing early detection and personalized treatment planning, while real-world evidence initiatives strengthen value-based care models. Patient advocacy networks and awareness campaigns have reduced stigma and boosted screening rates, creating demand for more holistic, multidisciplinary approaches that combine lifestyle modifications with medical and psychological interventions. As a result, collaboration among clinicians, technologists and policy makers has heightened, forging an ecosystem that prioritizes both efficacy and patient experience. In this era of convergence between digital health and behavioral science, organizations that embrace cross-sector partnerships and invest in scalable, data-driven solutions stand poised to redefine standards of care.

Cumulative Impact of 2025 United States Tariffs on Treatment Accessibility

In 2025, newly imposed United States tariffs on pharmaceutical imports have triggered cascading effects across the BED treatment supply chain. Tariffs on active ingredients used in anti-obesity medications and selective serotonin reuptake inhibitors have elevated raw material costs, prompting manufacturers to reassess sourcing strategies and renegotiate supplier contracts. Simultaneously, distribution channels-from outpatient clinics to retail pharmacies-face tightened margins that may translate into higher out-of-pocket expenses for patients. In response, several leading drugmakers are onshoring production or forging strategic alliances with domestic API producers to mitigate tariff impacts. Hospitals and clinics are also exploring bulk procurement agreements and group purchasing organizations to maintain cost-effectiveness in inpatient and outpatient services. Furthermore, providers are amplifying telehealth and online pharmacy options, leveraging digital channels to streamline fulfillment and reduce overhead. These adaptive measures collectively underscore both the vulnerabilities and resilience of the BED treatment market under shifting trade policies. Looking ahead, sustained collaboration between industry, policymakers and healthcare networks will be essential to safeguard affordability and ensure uninterrupted patient access to critical therapies.

Key Segmentation Insights Across Treatment, Distribution, Demographics, Comorbidity, End-Users, and Education

A nuanced understanding of market segments reveals critical opportunities and challenges across multiple dimensions. Based on treatment type, the landscape spans lifestyle and nutritional interventions-encompassing both mindful eating programs and nutritional counseling-alongside medication-based therapies that include anti-obesity drugs, anticonvulsants and antidepressants such as SSRIs and tricyclics, and therapy-driven approaches like CBT, DBT and interpersonal psychotherapy. Distribution channel analysis highlights the roles of hospitals and clinics-split between inpatient and outpatient services-alongside the growing influence of online pharmacies and traditional retail outlets. Patient demographics further stratify demand by age brackets (adolescents, adults, older adults), gender identities (female, male, non-binary) and socio-economic tiers (high, middle and low income), each segment exhibiting distinct care preferences and purchasing power. Comorbidity presence-ranging from anxiety and depression to substance abuse disorders-underscores the need for integrated treatment protocols. End-user categories span healthcare providers seeking evidence-based interventions, individual consumers pursuing self-guided support, and researchers shaping next-generation therapies. Finally, awareness and education initiatives-from community workshops to large-scale campaigns and online counseling programs-play a pivotal role in early detection and sustained recovery. Synthesizing these insights enables refined positioning and tailored strategies that address specific patient journeys and stakeholder priorities.

Key Regional Insights: Americas, EMEA, and Asia-Pacific Dynamics

Regional dynamics present divergent opportunities shaped by healthcare infrastructure, regulatory environments and cultural attitudes. In the Americas, robust reimbursement frameworks and advanced insurance models fuel adoption of comprehensive treatment packages, while telehealth penetration continues to accelerate in both urban and rural areas. Conversely, Europe, Middle East & Africa exhibits a heterogeneous regulatory landscape: mature markets in Western Europe combine public funding with private partnerships, whereas emerging economies prioritize capacity building and community-based interventions, often supported by non-governmental organizations. Across the Asia-Pacific region, rapid economic growth and expanding middle-class populations drive increased demand for both pharmacological and behavioral therapies, yet reimbursement pathways remain in flux, with government initiatives gradually recognizing BED as a distinct clinical entity. Cultural stigmas surrounding mental health vary widely, influencing patient engagement and disclosure rates. In each geography, tailored stakeholder engagement-whether aligning with payer requirements in North America, navigating regulatory diversity in EMEA or educating policymakers in APAC-will be instrumental in advancing patient access and driving market expansion.

Key Companies Driving Innovation and Treatment in Binge Eating Disorder

Innovation and competitive intensity are propelled by a diverse ecosystem of pharmaceutical manufacturers, specialized treatment centers and digital health pioneers. Pharmaceutical players such as Alsana, Inc., Alvogen and Amneal Pharmaceuticals, Inc. anchor the market with anti-obesity compounds and anticonvulsants, complemented by offerings from Hikma Pharmaceuticals PLC, Mallinckrodt PLC and Sun Pharmaceutical Industries Ltd. alongside emerging formulations from Takeda Pharmaceutical Company Limited and Viatris Inc. On the clinical front, treatment centers like BALANCE Eating Disorder Treatment Center, Carolina House and Timberline Knolls Residential Treatment Center deliver multidisciplinary inpatient and outpatient services, while recovery networks such as the Eating Recovery Center and Veritas Collaborative emphasize evidence-based therapies. Digital innovators including TalktoAngel and Equip Health Medical, P.C. are expanding online counseling and education platforms. Meanwhile, research institutions and academic centers collaborate with Rhodes Pharmaceuticals L.P. by Purdue Pharma L.P. and Ascent Pharmaceuticals, Inc. to advance novel treatment modalities. Natural Food Therapy and Monte Nido & Affiliates Holdings, LLC offer holistic nutrition-focused programs. Across this spectrum, strategic alliances and licensing partnerships are accelerating pipeline development and broadening treatment portfolios to meet evolving patient needs.

Actionable Recommendations for Industry Leaders

To capitalize on emerging trends and mitigate policy risks, industry leaders should pursue a combination of strategic initiatives. First, integrating digital health platforms with traditional care-linking teletherapy, online counseling and AI-enabled monitoring-to deliver personalized, scalable interventions. Second, diversifying supply chains through regional manufacturing partnerships and local API sourcing to insulate against trade-driven cost fluctuations. Third, tailoring therapies to distinct patient demographics by developing age- and gender-specific programs, and by addressing socio-economic barriers through tiered pricing and financial assistance schemes. Fourth, strengthening collaborations between pharmaceutical developers, academic researchers and treatment centers to accelerate evidence generation and streamline regulatory approvals. Fifth, embedding comorbidity screening within routine assessments to facilitate comprehensive, multidisciplinary care plans. Finally, amplifying community workshops and educational campaigns in underserved regions, leveraging digital outreach to raise awareness and reduce stigma. By adopting these focused actions, organizations can enhance care affordability, drive adherence and secure sustainable growth in the evolving BED treatment market.

Conclusion: Strategic Path Forward in Binge Eating Disorder Management

In summary, the BED treatment market is at a pivotal juncture defined by technological breakthroughs, policy realignments and deepened patient engagement. Shifts toward telehealth and digital therapeutics are expanding access, while evolving tariff regimes demand agile supply chain strategies. Detailed segmentation by treatment type, distribution channel, patient demographics and comorbidity presence underscores the importance of tailored solutions. Regional landscapes-from the well-established Americas to the regulatory mosaic of EMEA and the fast-growing Asia-Pacific-require bespoke market entry and expansion tactics. A competitive ecosystem of pharmaceutical innovators, specialized treatment centers and digital health platforms continues to push boundaries, driving new standards of care. Moving forward, success hinges on proactive collaboration across stakeholders, continuous investment in evidence-based interventions and an unwavering commitment to patient-centric models. By aligning strategic imperatives with emerging market trends, organizations can not only address the pressing needs of individuals with BED but also establish enduring leadership in this high-impact therapeutic area.

Market Segmentation & Coverage

This research report categorizes the Binge Eating Disorder Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Lifestyle and Nutritional Interventions
    • Mindful Eating Programs
    • Nutritional Counseling
  • Medication-Based Treatments
    • Anti-Obesity Drugs
    • Anticonvulsants
    • Antidepressants
      • Selective Serotonin Reuptake Inhibitors
      • Tricyclic Antidepressants
  • Therapy-Based Treatments
    • Cognitive Behavioral Therapy (CBT)
    • Dialectical Behavior Therapy (DBT)
    • Interpersonal Psychotherapy
  • Hospitals and Clinics
    • Inpatient Services
    • Outpatient Services
  • Online Pharmacies
  • Retail Pharmacies
  • Age Group
    • Adolescents
    • Adults
    • Older Adults
  • Gender
    • Female
    • Male
    • Non-Binary
  • Socio-Economic Status
    • High-Income Groups
    • Low-Income Groups
    • Middle-Income Groups
  • With Anxiety Disorders
  • With Depression
  • With Substance Abuse Disorders
  • Healthcare Providers
  • Individual Consumers
  • Researchers and Academics
  • Community Workshops
  • Educational Campaigns
  • Online Counseling Programs

This research report categorizes the Binge Eating Disorder Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Binge Eating Disorder Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Alsana, Inc.
  • Alvogen
  • Amneal Pharmaceuticals, Inc.
  • Apotex Inc.
  • Ascent Pharmaceuticals, Inc.
  • BALANCE Eating Disorder Treatment Center
  • Carolina House Eating Disorder Treatment Center
  • Center for Change
  • Eating Disorders Treatment Center
  • Eating Recovery Center
  • Equip Health Medical, P.C.
  • Hikma Pharmaceuticals PLC
  • Mallinckrodt PLC
  • Monte Nido & Affiliates Holdings, LLC
  • Montecatini Eating Disorder Treatment Center
  • Natural Food Therapy
  • Red Oak Recovery
  • Rhodes Pharmaceuticals L.P. by Purdue Pharma L.P.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • TalktoAngel
  • The London Centre for Eating Disorders and Body Image Ltd.
  • Timberline Knolls Residential Treatment Center
  • Veritas Collaborative
  • Viatris Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Binge Eating Disorder Market, by Treatment Type
8.1. Introduction
8.2. Lifestyle and Nutritional Interventions
8.2.1. Mindful Eating Programs
8.2.2. Nutritional Counseling
8.3. Medication-Based Treatments
8.3.1. Anti-Obesity Drugs
8.3.2. Anticonvulsants
8.3.3. Antidepressants
8.3.3.1. Selective Serotonin Reuptake Inhibitors
8.3.3.2. Tricyclic Antidepressants
8.4. Therapy-Based Treatments
8.4.1. Cognitive Behavioral Therapy (CBT)
8.4.2. Dialectical Behavior Therapy (DBT)
8.4.3. Interpersonal Psychotherapy
9. Binge Eating Disorder Market, by Distribution Channel
9.1. Introduction
9.2. Hospitals and Clinics
9.2.1. Inpatient Services
9.2.2. Outpatient Services
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Binge Eating Disorder Market, by Patient Demographics
10.1. Introduction
10.2. Age Group
10.2.1. Adolescents
10.2.2. Adults
10.2.3. Older Adults
10.3. Gender
10.3.1. Female
10.3.2. Male
10.3.3. Non-Binary
10.4. Socio-Economic Status
10.4.1. High-Income Groups
10.4.2. Low-Income Groups
10.4.3. Middle-Income Groups
11. Binge Eating Disorder Market, by Comorbidity Presence
11.1. Introduction
11.2. With Anxiety Disorders
11.3. With Depression
11.4. With Substance Abuse Disorders
12. Binge Eating Disorder Market, by End-User
12.1. Introduction
12.2. Healthcare Providers
12.3. Individual Consumers
12.4. Researchers and Academics
13. Binge Eating Disorder Market, by Awareness and Education Programs
13.1. Introduction
13.2. Community Workshops
13.3. Educational Campaigns
13.4. Online Counseling Programs
14. Americas Binge Eating Disorder Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Binge Eating Disorder Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Binge Eating Disorder Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Alsana, Inc.
17.3.2. Alvogen
17.3.3. Amneal Pharmaceuticals, Inc.
17.3.4. Apotex Inc.
17.3.5. Ascent Pharmaceuticals, Inc.
17.3.6. BALANCE Eating Disorder Treatment Center
17.3.7. Carolina House Eating Disorder Treatment Center
17.3.8. Center for Change
17.3.9. Eating Disorders Treatment Center
17.3.10. Eating Recovery Center
17.3.11. Equip Health Medical, P.C.
17.3.12. Hikma Pharmaceuticals PLC
17.3.13. Mallinckrodt PLC
17.3.14. Monte Nido & Affiliates Holdings, LLC
17.3.15. Montecatini Eating Disorder Treatment Center
17.3.16. Natural Food Therapy
17.3.17. Red Oak Recovery
17.3.18. Rhodes Pharmaceuticals L.P. by Purdue Pharma L.P.
17.3.19. Sun Pharmaceutical Industries Ltd.
17.3.20. Takeda Pharmaceutical Company Limited
17.3.21. TalktoAngel
17.3.22. The London Centre for Eating Disorders and Body Image Ltd.
17.3.23. Timberline Knolls Residential Treatment Center
17.3.24. Veritas Collaborative
17.3.25. Viatris Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BINGE EATING DISORDER MARKET MULTI-CURRENCY
FIGURE 2. BINGE EATING DISORDER MARKET MULTI-LANGUAGE
FIGURE 3. BINGE EATING DISORDER MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BINGE EATING DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BINGE EATING DISORDER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BINGE EATING DISORDER MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BINGE EATING DISORDER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BINGE EATING DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY MINDFUL EATING PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY NUTRITIONAL COUNSELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ANTI-OBESITY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY (CBT), BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY DIALECTICAL BEHAVIOR THERAPY (DBT), BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY INTERPERSONAL PSYCHOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY INPATIENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY OUTPATIENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY OLDER ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY GENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY NON-BINARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY HIGH-INCOME GROUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY LOW-INCOME GROUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY MIDDLE-INCOME GROUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY WITH ANXIETY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY WITH DEPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY WITH SUBSTANCE ABUSE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY INDIVIDUAL CONSUMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY RESEARCHERS AND ACADEMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY COMMUNITY WORKSHOPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY EDUCATIONAL CAMPAIGNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BINGE EATING DISORDER MARKET SIZE, BY ONLINE COUNSELING PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2018-2030 (USD MILLION)
TABLE 102. CANADA BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 103. CANADA BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 104. CANADA BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 105. CANADA BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 106. CANADA BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 107. CANADA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. CANADA BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 109. CANADA BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 110. CANADA BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 111. CANADA BINGE EATING DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 112. CANADA BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, 2018-2030 (USD MILLION)
TABLE 113. CANADA BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2018-2030 (USD MILLION)
TABLE 114. CANADA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. CANADA BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2018-2030 (USD MILLION)
TABLE 116. MEXICO BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 117. MEXICO BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 119. MEXICO BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 120. MEXICO BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 121. MEXICO BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. MEXICO BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 123. MEXICO BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 124. MEXICO BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 125. MEXICO BINGE EATING DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 126. MEXICO BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, 2018-2030 (USD MILLION)
TABLE 127. MEXICO BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2018-2030 (USD MILLION)
TABLE 128. MEXICO BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. MEXICO BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES BINGE EATING DISORDER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 148. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 150. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 152. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 153. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 154. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, 2018-2030 (USD MILLION)
TABLE 156. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2018-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2018-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC BINGE EATING DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 161. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 162. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 163. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 164. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 165. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 167. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 168. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 169. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 170. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, 2018-2030 (USD MILLION)
TABLE 171. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2018-2030 (USD MILLION)
TABLE 172. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. AUSTRALIA BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2018-2030 (USD MILLION)
TABLE 174. CHINA BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 175. CHINA BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 176. CHINA BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 177. CHINA BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 178. CHINA BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 179. CHINA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. CHINA BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 181. CHINA BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 182. CHINA BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 183. CHINA BINGE EATING DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 184. CHINA BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, 2018-2030 (USD MILLION)
TABLE 185. CHINA BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2018-2030 (USD MILLION)
TABLE 186. CHINA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. CHINA BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2018-2030 (USD MILLION)
TABLE 188. INDIA BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 189. INDIA BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 190. INDIA BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 191. INDIA BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 192. INDIA BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 193. INDIA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. INDIA BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 195. INDIA BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 196. INDIA BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 197. INDIA BINGE EATING DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 198. INDIA BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, 2018-2030 (USD MILLION)
TABLE 199. INDIA BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2018-2030 (USD MILLION)
TABLE 200. INDIA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. INDIA BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 204. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 205. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 206. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 207. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 209. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 210. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 211. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 212. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, 2018-2030 (USD MILLION)
TABLE 213. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2018-2030 (USD MILLION)
TABLE 214. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. INDONESIA BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2018-2030 (USD MILLION)
TABLE 216. JAPAN BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 217. JAPAN BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 218. JAPAN BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 219. JAPAN BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 220. JAPAN BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 221. JAPAN BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. JAPAN BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 223. JAPAN BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 224. JAPAN BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 225. JAPAN BINGE EATING DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 226. JAPAN BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, 2018-2030 (USD MILLION)
TABLE 227. JAPAN BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2018-2030 (USD MILLION)
TABLE 228. JAPAN BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. JAPAN BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2018-2030 (USD MILLION)
TABLE 230. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 231. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 232. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 233. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 234. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 235. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 237. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 238. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 239. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 240. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, 2018-2030 (USD MILLION)
TABLE 241. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2018-2030 (USD MILLION)
TABLE 242. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 243. MALAYSIA BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2018-2030 (USD MILLION)
TABLE 244. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 245. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 246. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 247. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 248. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 249. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 253. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 254. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2018-2030 (USD MILLION)
TABLE 256. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 257. PHILIPPINES BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2018-2030 (USD MILLION)
TABLE 258. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 259. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 260. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 261. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 265. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 267. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 268. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, 2018-2030 (USD MILLION)
TABLE 269. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2018-2030 (USD MILLION)
TABLE 270. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 271. SINGAPORE BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 277. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 279. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 280. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 281. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 282. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, 2018-2030 (USD MILLION)
TABLE 283. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2018-2030 (USD MILLION)
TABLE 284. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 285. SOUTH KOREA BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2018-2030 (USD MILLION)
TABLE 286. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 287. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 288. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 289. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 290. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 291. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 293. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 294. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 295. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 296. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, 2018-2030 (USD MILLION)
TABLE 297. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2018-2030 (USD MILLION)
TABLE 298. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 299. TAIWAN BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2018-2030 (USD MILLION)
TABLE 300. THAILAND BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 301. THAILAND BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 302. THAILAND BINGE EATING DISORDER MARKET SIZE, BY MEDICATION-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 303. THAILAND BINGE EATING DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 304. THAILAND BINGE EATING DISORDER MARKET SIZE, BY THERAPY-BASED TREATMENTS, 2018-2030 (USD MILLION)
TABLE 305. THAILAND BINGE EATING DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. THAILAND BINGE EATING DISORDER MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 307. THAILAND BINGE EATING DISORDER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 308. THAILAND BINGE EATING DISORDER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 309. THAILAND BINGE EATING DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 310. THAILAND BINGE EATING DISORDER MARKET SIZE, BY SOCIO-ECONOMIC STATUS, 2018-2030 (USD MILLION)
TABLE 311. THAILAND BINGE EATING DISORDER MARKET SIZE, BY COMORBIDITY PRESENCE, 2018-2030 (USD MILLION)
TABLE 312. THAILAND BINGE EATING DISORDER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 313. THAILAND BINGE EATING DISORDER MARKET SIZE, BY AWARENESS AND EDUCATION PROGRAMS, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM BINGE EATING DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM BINGE EATING DISORDER MARKET SIZE, BY LIFESTYLE AND NUTRITIONAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 316. V

Companies Mentioned

  • Alsana, Inc.
  • Alvogen
  • Amneal Pharmaceuticals, Inc.
  • Apotex Inc.
  • Ascent Pharmaceuticals, Inc.
  • BALANCE Eating Disorder Treatment Center
  • Carolina House Eating Disorder Treatment Center
  • Center for Change
  • Eating Disorders Treatment Center
  • Eating Recovery Center
  • Equip Health Medical, P.C.
  • Hikma Pharmaceuticals PLC
  • Mallinckrodt PLC
  • Monte Nido & Affiliates Holdings, LLC
  • Montecatini Eating Disorder Treatment Center
  • Natural Food Therapy
  • Red Oak Recovery
  • Rhodes Pharmaceuticals L.P. by Purdue Pharma L.P.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • TalktoAngel
  • The London Centre for Eating Disorders and Body Image Ltd.
  • Timberline Knolls Residential Treatment Center
  • Veritas Collaborative
  • Viatris Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Binge eating Disorder Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Binge eating Disorder Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Binge Eating Disorder Market Report and Forecast 2024-2032 - Product Image

Binge Eating Disorder Market Report and Forecast 2024-2032

  • Report
  • 250 Pages
  • Global
From
Binge-Eating Disorder - Pipeline Insight, 2025 - Product Image

Binge-Eating Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Binge-Eating Disorder Treatment Market 2024-2028 - Product Image

Binge-Eating Disorder Treatment Market 2024-2028

  • Report
  • 164 Pages
  • Global
From
Eating Disorder Clinics in the US - Industry Market Research Report - Product Image

Eating Disorder Clinics in the US - Industry Market Research Report

  • Report
  • 73 Pages
  • United States
From

About the Binge Eating Disorder Market

Binge Eating Disorder (BED) is a mental health disorder characterized by recurrent episodes of eating large amounts of food in a short period of time, accompanied by feelings of guilt, shame, and distress. BED is the most common eating disorder in the United States, affecting an estimated 3.5% of adults. It is more common in women than men, and is associated with a range of physical and psychological health problems. Treatment for BED typically involves a combination of psychotherapy, nutritional counseling, and medication. Cognitive Behavioral Therapy (CBT) is the most commonly used form of psychotherapy, and is designed to help individuals identify and modify unhealthy eating behaviors. Nutritional counseling focuses on helping individuals develop healthy eating habits and improve their relationship with food. Medications such as antidepressants and anti-obesity drugs may also be used to help reduce binge eating episodes. There are a number of companies that provide services related to BED, including online therapy providers, nutritionists, and pharmaceutical companies. Examples include Talkspace, NutriSavings, and Orexigen Therapeutics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.